In this episode of Trending Health, we explore how the Inflation Reduction Act (IRA) is reshaping strategy across the life sciences industry. Mindy McGrath is joined by Inizio Ignite colleagues, Scott Briggs and Ethan Johnson, to discuss how manufacturers are responding to Medicare price negotiation, Part D redesign, and increasing pressures on pricing and access. The conversation highlights what…
The brain health economy is emerging as a critical focus across healthcare and policy both for treating serious neurological and mental health diseases and for increasing brain capital for society. In this episode, Inizio Ignite’s Varun Renjen sits down with George Vradenburg, Chairman of the Davos Alzheimer\’s Collaborative and Harris Eyre, Executive Director of the Global Brain Economy…
In this news episode of Trending Health, Mindy McGrath and Everly Petruzzelli break down the evolving regulatory landscape at the FDA and what it means for life sciences leaders. This episode covers: Staff changes to the FDA and approval pathway pilot programs Rising scrutiny on trial design — especially in rare disease The FDA’s firmer stance on compounded GLP-1s as shortages ease From regulatory…
As 2026 begins, pharma leaders are placing sharper bets earlier while navigating increasing pressure across pricing, access, and evidence. In this episode, Matt Riordan, Group President, Putnam, shares a candid, executive-level view of what leaders are prioritizing this year, where confidence is high, and where blind spots may limit impact. Drawing on real-world leadership conversations, the…
As we kick off 2026, Mindy sits down with Inizio Ignite Global President, Remco op den Kelder, to discuss the industry forces shaping the year ahead for life sciences companies. Panel – Mindy McGrath, Remco op den Kelder Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com .
The rules of product launch are changing fast. Policy reform, payer pressure, AI adoption, and shifting system dynamics are redefining how life sciences companies prepare for market. In this episode, Summer Atkinson sits down with Vynamic Health Industry Advisor Mindy McGrath to unpack the biggest forces impacting launches today—from accelerating decision-making to growing health system…
In recent years, there has been renewed interest in psychedelic treatment for a variety of medical conditions ranging from depression to trauma, and even dementia, which has left countless people searching for real recovery. This exciting research is challenging the limits of what’s possible. Psychedelic compounds, once misunderstood or dismissed, are now being studied for their ability to promote…
The traditional path to patients is being rewritten. As affordability pressures rise and patient expectations shift, life sciences companies are rethinking the middle — moving beyond payers, providers, and pharmacies to create direct, digital pathways that meet patients where they are. In this episode, host Adrea Cope is joined by Colleen Ferlotti and Rupa Mehta to unpack the rapid rise of…
As Gen Z steps into the healthcare workforce, they’re bringing new expectations for authenticity, technology, and purpose-driven brands. The old pharma playbook? Invisible to this generation. In this episode of Trending Health, host Adrea Cope sits down with Carolyn Frantz and Mindy McGrath to explore how life sciences marketers can evolve to engage the next generation of HCPs and patients — from…
With external shifts in regulatory uncertainty tied to the IRA, payer pressures, shifting Federal and state policies, and broader scrutiny around pricing, Life Science companies are transforming their operations to deliver better value, grow, and create meaningful impact in the future. In this last episode of the Strategic Transformation series, Mindy McGrath is joined by Karen Baldry and Andrew…